Yayın: Catecholaminergic and Cholinergic Systems Mediate Beneficial Effect of Vortioxetine on Diabetes-Induced Neuropathic Pain
| dc.contributor.author | TURAN YÜCEL, NAZLI | |
| dc.contributor.author | DEMİR ÖZKAY, ÜMİDE | |
| dc.contributor.author | CAN, ÖZGÜR DEVRİM | |
| dc.contributor.author | Ümide Demir Özkay | |
| dc.contributor.author | Özgür Devrim Can | |
| dc.contributor.orcid | 0000-0002-0371-2703 | |
| dc.contributor.orcid | 0000-0003-3314-1961 | |
| dc.contributor.orcid | 0000-0002-5470-0139 | |
| dc.contributor.orcid | 0000-0002-6773-4266 | |
| dc.contributor.orcid | 0000-0002-2260-3174 | |
| dc.date.accessioned | 2025-11-13T11:00:20Z | |
| dc.date.issued | 2023-04-10 | |
| dc.identifier.doi | https://doi.org/10.3390/biomedicines11041137 | |
| dc.identifier.endpage | 1137 | |
| dc.identifier.issn | 2227-9059 | |
| dc.identifier.issue | 4 | |
| dc.identifier.openalex | W4363648330 | |
| dc.identifier.startpage | 1137 | |
| dc.identifier.uri | https://hdl.handle.net/11421/5927 | |
| dc.identifier.uri | https://doi.org/10.3390/biomedicines11041137 | |
| dc.identifier.volume | 11 | |
| dc.language.iso | en | |
| dc.relation.ispartof | Biomedicines | |
| dc.rights | openAccess | |
| dc.subject | Vortioxetine | |
| dc.subject | Neuropathic pain | |
| dc.subject | Allodynia | |
| dc.subject | Pharmacology | |
| dc.subject | Hyperalgesia | |
| dc.subject | Medicine | |
| dc.subject | Cholinergic | |
| dc.subject | Neuralgia | |
| dc.subject | Endocrinology | |
| dc.subject | Anesthesia | |
| dc.subject | Antidepressant | |
| dc.subject | Internal medicine | |
| dc.subject | Nociception | |
| dc.subject | Receptor | |
| dc.subject | Hippocampus | |
| dc.subject.sdg | 3 | |
| dc.title | Catecholaminergic and Cholinergic Systems Mediate Beneficial Effect of Vortioxetine on Diabetes-Induced Neuropathic Pain | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.authorid.openalex | A5018664863 | |
| local.authorid.openalex | A5017325490 | |
| local.authorid.openalex | A5020313406 |
